0 NYSE Companies - October 31, 2024Cohen & Company Sets Release and Conference Call Date for Third Quarter 2024 Financial ResultsPHILADELPHIA and NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) — Cohen & Company Inc. (NYSE American: COHN) will release its […]Read More
0 NYSE Companies - October 31, 2024Gatos Silver Third Quarter 2024 Results Conference Call and WebcastVANCOUVER, British Columbia, Oct. 31, 2024 (GLOBE NEWSWIRE) — Gatos Silver, Inc. (NYSE/TSX: GATO) (“Gatos Silver” or the “Company”) will […]Read More
0 NYSE Companies - October 31, 2024NL INDUSTRIES ANNOUNCES QUARTERLY DIVIDEND FOR THE FOURTH QUARTER OF 2024 AT $.08 PER SHAREDallas, Texas, Oct. 31, 2024 (GLOBE NEWSWIRE) — NL Industries, Inc. (NYSE: NL) today announced that its board of directors […]Read More
0 NASDAQ Companies - October 31, 2024Supernus Presents Promising Data from Open-Label Phase 2a Study of SPN-820 Data in Major Depressive Disorder at Psych Congress 2024Participants in the Phase 2a study experienced rapid and meaningful decreases in depressive symptoms Suicidal ideation decreased by 80% SPN-820 […]Read More
0 NYSE Companies - October 31, 2024Sonoco Reports Third Quarter 2024 ResultsHARTSVILLE, S.C., Oct. 31, 2024 (GLOBE NEWSWIRE) — Sonoco Products Company (“Sonoco” or the “Company”) (NYSE: SON), one of the […]Read More
0 NYSE Companies - October 31, 2024Navios Maritime Partners L.P. Announces the Date for the Release of Third Quarter Ended September 30, 2024 Results, Conference Call and WebcastMONACO, Oct. 31, 2024 (GLOBE NEWSWIRE) — Navios Maritime Partners L.P. (“Navios Partners”) (NYSE:NMM) announced today that it will host […]Read More
0 NYSE Companies - October 31, 2024Do Not Distribute – TEST #2OMAHA, Neb., Oct. 31, 2024 (GLOBE NEWSWIRE) — West Corporation (Nasdaq:WSTC), a global provider of communication and network infrastructure services, […]Read More
0 NASDAQ Companies - October 31, 2024INmune Bio Inc. Announces Third Quarter 2024 Results and Provides Business UpdateBOCA RATON, Fla., Oct. 31, 2024 (GLOBE NEWSWIRE) — INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology […]Read More